Age-related macular degeneration and quality of life: how to interpret a research paper in health-related quality of life.
about
Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study.Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering.The Relationship Between Low Vision and Musculoskeletal Complaints. A Case Control Study Between Age-related Macular Degeneration Patients and Age-matched Controls with Normal Vision.Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25).
P2860
Age-related macular degeneration and quality of life: how to interpret a research paper in health-related quality of life.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Age-related macular degenerati ...... ealth-related quality of life.
@ast
Age-related macular degenerati ...... ealth-related quality of life.
@en
type
label
Age-related macular degenerati ...... ealth-related quality of life.
@ast
Age-related macular degenerati ...... ealth-related quality of life.
@en
prefLabel
Age-related macular degenerati ...... ealth-related quality of life.
@ast
Age-related macular degenerati ...... ealth-related quality of life.
@en
P1476
Age-related macular degenerati ...... ealth-related quality of life.
@en
P2093
Alejandro Oliver-Fernandez
Sanjay Sharma
P304
P356
10.1097/01.ICU.0000124082.88389.CF
P577
2004-06-01T00:00:00Z